10x Insights
Loading account…
Companies / Healthcare / Modular Medical, Inc.
MODD

Modular Medical, Inc.

HealthcareSurgical & Medical Instruments
Ticker MODDSAN DIEGO, CAFiscal year ends MarchBook value per share $1.97Diluted shares 5.5M

Modular Medical, Inc. (Nasdaq: MODD) is a medical device company focused on designing, developing, and commercializing innovative insulin pumps using modernized technology to expand pump adoption among people with diabetes. The company's website is located at PivotPump.com. From the company’s description.

Fiscal year 2026 · ends 03-31Changes are against fiscal 2025The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
—
0.00%
$-28.24M
−50.0% year over year
Last 12 mo $-28.03M
-217.93%
−107.7 percentage points
Last 12 mo -260.37%
Cash & financing
$-23.75M
−51.1% year over year
Last 12 mo $-24.35M
$-27.68M
−52.0% year over year
Last 12 mo $-28.04M
—
2.3M
−93.8% year over year
Last 12 mo 5.5M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Modular Medical, Inc. does

In the company’s own words

Modular Medical, Inc. (Nasdaq: MODD) is a medical device company focused on designing, developing, and commercializing innovative insulin pumps using modernized technology to expand pump adoption among people with diabetes. The company's website is located at PivotPump.com.

The company's core product is the Pivot insulin delivery system, a tubeless patch pump that integrates the infusion set into a removable, wearable device. The Pivot received FDA clearance in April 2026 and commenced commercial availability and initial patient shipments in June 2026. The company does not intend to commercialize its earlier MODD1 product, which received FDA clearance in September 2024. Modular Medical is pursuing a differentiated go-to-market strategy utilizing distributors to reach primary care physicians managing daily insulin users and a targeted direct sales force engaging diabetes educator practices.

The company targets two primary market segments: Type 1 diabetes patients and Type 2 diabetes patients requiring intensive insulin therapy. Modular Medical specifically focuses on a market segment it identifies as "Almost Pumpers"—insulin-requiring individuals aware of pump benefits but deterred by complexity, cost, and cumbersome design of existing products. The company estimates this addressable market at approximately $3 billion, representing roughly 32 percent of the Type 1 diabetes market.

Modular Medical's Pivot pump features a simplified one-button interface, holds a full 3-milliliter insulin capacity, requires only nine setup and refill steps every 72 hours compared to 42 steps for competitors, and incorporates reusable pump technology with disposable cartridges and infusion sets. The pump weighs 20 grams empty and operates without external controllers, charging requirements, or battery replacement.

The company has established its initial production line with Phillips Medisize, a Molex company, a tier-one medical device manufacturer. Modular Medical is pursuing Conformite Europeenne mark clearance for international expansion, with expected approval by the second quarter of 2027. The company intends to expand commercial activities across metropolitan markets in the United States by late 2026 and plans to develop future products with phone-based control and automated insulin delivery capabilities integrated with continuous glucose monitors.

Company details
Sector
Healthcare
Industry
Surgical & Medical Instruments
Headquarters
SAN DIEGO, CA
Fiscal year end
March
CIK
1074871
SIC
3841

Financial performance, year by year

Fiscal 2015–2026 · USD
$-31.07M$-22.59M$-14.12M$-5.65M$2.82M2015201620172017201820192020202120222023202420252026Last 12 moLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Modular Medical, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

6
funds hold it
0 of 35
superinvestors hold it
$0.55M
held by funds, at market
1.5%
of shares held by funds

Largest fund holders · Modular Medical, Inc.’s weight in each

VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.00%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
Fidelity Extended Market Index Fund
FSMAX · Fidelity Concord Street Trust
0.00%of fund net assets
Fidelity Nasdaq Composite Index Fund
FNCMX · Fidelity Concord Street Trust
0.00%of fund net assets
Fidelity Total Market Index Fund
FSKAX · Fidelity Concord Street Trust
0.00%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Could not be determined for this company: bond issues.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Modular Medical, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Modular Medical, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Modular Medical, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.